跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,916 条关于
“Curadh MTR”
全部
1,916
临床试验
1,387
药物
378
机构
30
资讯
121
去年
Alpha Fusion and Curadh Form Strategic Partnership to Advance Astatine-211 Radiopharmaceuticals
去年
TD2 Oncology and Curadh Form Strategic Partnership to Accelerate Radiopharmaceutical Development for Solid Tumors
去年
Health Disparities in HIV Care: New Study Reveals Critical Gaps and Strategies for Improving Access
去年
Compass Therapeutics Receives FDA Fast Track Designation for CTX-009 Bispecific Antibody
2个月前
Northwell Health Appoints Brian S. Kim as First Chief Biotechnology Officer to Accelerate Bioelectronic Medicine Commercialization
去年
SetPoint Medical's Neuroimmune Modulation Platform Receives FDA IDE Approval for Relapsing-Remitting MS Trial
2年前
rTMS Shows Promise in Improving Functional Outcomes for Multiple Sclerosis Patients
10个月前
Rakovina Therapeutics Presents AI-Discovered CNS-Penetrant ATR/mTOR Dual Inhibitors at Neuro-Oncology Meeting
9个月前
Monte Rosa Therapeutics Reports Promising MRT-8102 Cardiovascular Data and Prepares Updated MRT-2359 Cancer Results
去年
CytoSorbents' DrugSorb-ATR Receives FDA Priority Review for Bleeding Reduction in Heart Surgery
第 1 页,共 13 页
上一页
下一页